Cereno Scientific AB logo

CRNO TO1 B - Cereno Scientific AB News Story

SEK0.41 0.0  0.0%

Last Trade - 04/03/21

Sector
Healthcare
Size
Micro Cap
Market Cap £11.5m
Enterprise Value £6.71m
Revenue £n/a
Position in Universe 1530th / 1850

BRIEF-Cereno Scientific Initiates Collaboration With Cro Partner Oct To Conduct A Phase Ii Study

Tue 26th June, 2018 7:48am
Cereno Scientific AB  CRNOSb.TE :
    * CERENO SCIENTIFIC INITIATES COLLABORATION WITH CRO PARTNER
OCT
TO CONDUCT A PHASE II STUDY
    * CONDUCT A PHASE II STUDY TO INVESTIGATE ANTITHROMBOTIC
EFFECTS
OF CERENOS CANDIDATE DRUG CS1.

Source text for Eikon:  ID:nWkr5br2V0 
Further company coverage:  CRNOSb.TE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.